The maturational theory of brain development and cerebral excitability in the multifactorially inherited manic-depressive psychosis and schizophrenia

https://doi.org/10.1016/0167-8760(94)90005-1Get rights and content

Abstract

An association has been established between the multifactorially inherited rate of physical maturation and the final step in brain development, when some 40% of synapses are eliminated. This may imply that similarly to endocrine disease entities, we have cerebral disease entities at the extremes of the maturational rate continuum. The restriction of prepubertal pruning to excitatory synapses leaving the number of inhibitory ones fairly constant, implies changes in cerebral excitability as a function of rate of maturation (age at puberty). In early maturation there will be an excess in excitatory drive due to prematurely abridged pruning, which compounds a synchronization tendency inherent in excessive synaptic density. Lowering excitatory level with antiepileptics is hypothesized to be a logical treatment in this type of brain dysfunction. In late maturation, a deficit in excitatory drive due to failure to shut down the pruning process associated with a tendency to the breakdown of circuitry and desynchronization, adds to a similar adversity inherent in reduced synaptic density. Raising the excitatory level with convulsants is hypothesized to be the treatment for this type of CNS dysfunction. The maturational theory of Kraepelin's psychoses holds that they are naturally occuring contrasting chemical signaling disorders in the brain at the extremes of the maturational rate continuum: manic depressive psychosis is a disorder of the early maturer and comprises raised cerebral excitability and a raised density of synapses. This is successfully treated with anti-epileptics like sodium valproate and carbamazepin. Schizophrenia is a disorder in late maturation with reduced cerebral excitability and reduced synaptic density. This is accordingly treated with convulsants such as typical and atypical neuroleptics. However, the conventional effective treatments in both disorders act on inhibition only by either lowering or raising inhibitory level. While the neuroleptics drugs are superior anti-psychotics they nevertheless do not affect the deviation in cerebral excitability which would explain why they do not cure. Disturbed circadian rhythms which precede psychotic episodes in manic depressives accord with a primary dysfunction in the CNS, the suprachiasmatic nucleus of the hypothalamus via its direct input the glutamatergic retinohypothalamic tract. The residual deficits in schizophrenia accord with persistently disconnected circuitry and communication which is a consequence of reduced excitatory level and is manifested in insufficient motivation, a reduced drive associated hypofunction, and neuromuscular dysfunction.

References (110)

  • N. Motohashi et al.

    GABA-B receptors are upregulated by chronic treatment with lithium or carbamezapine

    Eur. J. Pharmacol.

    (1989)
  • J.W. Olney

    Excitatory amino acids and neuropsychiatric disorders

    Biol. Psychiat.

    (1989)
  • S.I. Rapoport

    Integrated phylogeny of the primate brain, with special reference to humans and their disease

    Brain Res. Rev.

    (1990)
  • L.F. Saugstad

    Is persistent pelvic pain and pelvic joint instability associated with early menarche and with oral contraceptives?

    Eur. J. Obstet. Gynecol. Reprod. Biol.

    (1991)
  • G. Ashcroft

    Biochemistry and pathology of the affective psychoses

  • M. Barinaga

    Knockouts shed light on learning

    Science

    (1992)
  • M. Barinaga

    The brain remaps its own concourse

    Science

    (1992)
  • M. Barinaga

    Death gives birth to the nervous system. But how?

    Science

    (1993)
  • T.V. Bliss et al.

    A synaptic model of memory: longterm potentiation in the hippocampus (Review)

    Nature

    (1993)
  • J. Borg et al.

    Muscle biopsy findings, conduction velocity and refractory period of single motor nerve fibres in schizophrenia

    J. Neurol. Neurosurg. Psychiat.

    (1987)
  • P. Boyce et al.

    Seasonal affective disorder in the southern hemisphere

    Am. J. Psychiat.

    (1988)
  • P.H. Bradley

    Pharmacology of anti-psychotic drugs

  • V. Braitenberg

    Cortical architectonics

  • A. Breier et al.

    Brain Morphology and Schizophrenia

  • D.P. Cantwell et al.

    Anorexia nervosa and affective disorder

    Arch. Gen. Psychiat.

    (1977)
  • B.J. Carrol

    Psychopathology and neurobiology of manic-depressive disorders

  • J.-P. Changeux

    Chemical signaling in the brain

    Sci. Am.

    (1993)
  • D.W. Choi

    Bench to bedside: the glutamate connection

    Science

    (1992)
  • H.T. Chugani

    Glucose metabolism in the developing brain: correlations with synaptogenesis, plasticity and epilepsy

    Neuropsychopharmacology

    (1994)
  • H.T. Chugani et al.

    Reply

    Ann. Neurol.

    (1988)
  • W.M. Cowan et al.

    Regressive events in neurogenesis

    Science

    (1984)
  • J.T. Coyle et al.

    Oxidative stress, glutamate and neurodegenerative disorders

    Science

    (1991)
  • S. Cullheim et al.

    Postnatal synaptic reorganization of Cat motoneurons

  • R.A. Depue et al.

    Conceptualizing a serotonic trait

    Ann. N.Y. Acad. Sci.

    (1986)
  • G.M. Edelman

    Neural Darwinism: The Theory of Neuronal Group Selection

    (1987)
  • J.A. Egeland et al.

    Bipolar affective disorder linked to DNA markers on chromosome 11

    Nature

    (1987)
  • H.M. Emrich et al.

    Effects of sodium valproate on mania: the GABA hypothesis of affective disorders

    Arch. Psychiat. Nervenkr.

    (1980)
  • M.A. Flaum et al.

    Decreased cranial and cerebral volume in schizophrenia. A magnetic resonance imaging study

  • E. Fox

    Sport Physiology

    (1984)
  • S. Gershon et al.

    Pharmacological agents as tools in psychiatric research

  • K.L. Goa et al.

    Lamotrigine

    Drugs

    (1993)
  • P. Goldman-Rakic

    Changing concepts of cortical connectivity: parallel distributed cortical networks

    Annu. Rev. Neurosci.

    (1988)
  • F.K. Goodwin et al.

    Evidence that the pathophysiology of depression and the mechanisms of action of antidepressant drugs both involve alterations in circadian rhythms

  • I. Gorza et al.

    Slow to fast transformation of denervated soleus muscle

    J. Physiol.

    (1988)
  • S. Gupta et al.

    Neurological soft signs in neuroleptic naive schizophrenic patients vs normal controls

    Schiz. Res.

    (1994)
  • R.E. Hoffman et al.

    Cortical pruning and the development of schizophrenia: a computer model

    Schiz. Bull.

    (1989)
  • R.E. Hoffman et al.

    Parallel distributed processing and the emergence of schizophrenic symptoms

    Schiz. Bull.

    (1993)
  • J.A. Horne

    Why We Sleep: the functions of sleep in humans and other mammals

    (1980)
  • J.I. Hudson et al.

    Bulimia and major affective disorder. Experience with 105 patients

    Psychiat. Psychobiol.

    (1988)
  • P.K. Huttenlocher

    Synapse elimination and plasticity in developing human cerebral cortex

    Am. J. Mental Defic.

    (1984)
  • Cited by (0)

    View full text